Furthermore, the interaction between SMADs’ partners and HIF-1α favors metabolic reprogramming and tumor progression by benefiting PKM2 expression, an isoform prevalent in tumor cells, providing proliferating cells with differential control over glycolytic flux [74]. This evidence concerns the gene PKM and neoplasm.